Helix Biopharma Corp Stock Price on August 27, 2024

HBP Stock  CAD 0.97  0.03  3.00%   
Below is the normalized historical share price chart for Helix BioPharma Corp extending back to June 03, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Helix BioPharma stands at 0.97, as last reported on the 23rd of December, with the highest price reaching 0.97 and the lowest price hitting 0.97 during the day.
200 Day MA
1.0599
50 Day MA
0.9002
Beta
(0.84)
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Helix Stock, it is important to understand the factors that can impact its price. As of now, Helix Stock is out of control. Helix BioPharma Corp holds Efficiency (Sharpe) Ratio of 8.0E-4, which attests that the entity had a 8.0E-4% return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Helix BioPharma Corp, which you can use to evaluate the volatility of the firm. Please check out Helix BioPharma's Standard Deviation of 8.36, insignificant risk adjusted performance, and Market Risk Adjusted Performance of (0.02) to validate if the risk estimate we provide is consistent with the expected return of 0.0065%.
  
At this time, Helix BioPharma's Common Stock Shares Outstanding is very stable compared to the past year. As of the 23rd of December 2024, Stock Based Compensation is likely to grow to about 3.7 M, though Total Stockholder Equity is likely to grow to (85.5 K). . At this time, Helix BioPharma's Price To Sales Ratio is very stable compared to the past year. As of the 23rd of December 2024, Price Sales Ratio is likely to grow to 20.62, while Price Earnings Ratio is likely to drop (5.80). Helix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 8.0E-4

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsHBP

Estimated Market Risk

 8.46
  actual daily
75
75% of assets are less volatile

Expected Return

 0.01
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average Helix BioPharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Helix BioPharma by adding Helix BioPharma to a well-diversified portfolio.
Price Book
77.464
Book Value
(0)
Enterprise Value
46.5 M
Enterprise Value Ebitda
(6.36)
Shares Float
44 M

Helix BioPharma Valuation on August 27, 2024

It is possible to determine the worth of Helix BioPharma on a given historical date. On August 27, 2024 Helix was worth 1.15 at the beginning of the trading date compared to the closed value of 1.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Helix BioPharma stock. Still, in general, we apply an absolute valuation method to find Helix BioPharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Helix BioPharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Helix BioPharma's related companies.
 Open High Low Close Volume
  1.15    1.15    1.15    1.15    120.00  
08/27/2024
  1.15    1.15    1.15    1.15    1.00  
  1.15    1.15    1.15    1.15    1.00  
Backtest Helix BioPharma  |  Helix BioPharma History  |  Helix BioPharma Valuation   PreviousNext  
Open Value
1.15
1.15
Closing Value
26.54
Upside

Helix BioPharma Trading Date Momentum on August 27, 2024

On August 28 2024 Helix BioPharma Corp was traded for  1.15  at the closing time. The maximum traded price for the trading interval was 1.15  and the lowest daily price was  1.15 . There was no trading activity during the period 1.0. Lack of trading volume on 28th of August 2024 did not cause price change. The trading delta at closing time to the closing price today is 13.04% .

Helix BioPharma Corp Fundamentals Correlations and Trends

By evaluating Helix BioPharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Helix BioPharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Helix financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Helix BioPharma Stock history

Helix BioPharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Helix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Helix BioPharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Helix BioPharma stock prices may prove useful in developing a viable investing in Helix BioPharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding44.5 M46.7 M
Net Loss-7.2 M-7.6 M

Helix BioPharma Stock Technical Analysis

Helix BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Helix BioPharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Helix BioPharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Helix BioPharma Period Price Range

Low
December 23, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Helix BioPharma Corp cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Helix BioPharma December 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Helix BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Helix BioPharma shares will generate the highest return on investment. By undertsting and applying Helix BioPharma stock market strength indicators, traders can identify Helix BioPharma Corp entry and exit signals to maximize returns

Helix BioPharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Helix BioPharma's price direction in advance. Along with the technical and fundamental analysis of Helix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Helix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Other Information on Investing in Helix Stock

Helix BioPharma financial ratios help investors to determine whether Helix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioPharma security.